News, Events & Resources
There’s a lot happening at Melinta. We are the company of the moment and enterprise of the future. Join us in realizing our vision — this is our story, and it’s going to be legendary.
Melinta Therapeutics President and CEO Christine Ann Miller Elected to Board of Directors of Iveric Bio
Melinta Therapeutics President and CEO Christine Ann Miller Elected to Board of Directors of Iveric Bio
January 6, 2022Press ReleaseMelinta Therapeutics President and CEO Christine Ann Miller Elected to Board of Directors of Iveric Bio MORRISTOWN, N.J., Jan. 6, 2022 — Melinta Therapeutics, LLC...
Melinta Therapeutics Announces Appointment of Doug Girgenti as Vice President of Drug Development
Melinta Therapeutics Announces Appointment of Doug Girgenti as Vice President of Drug Development
October 25, 2021Press ReleaseMelinta Therapeutics Announces Appointment of Doug Girgenti as Vice President of Drug Development MORRISTOWN, N.J., Oct. 25, 2021 — Melinta Therapeutics, LLC...
Melinta Therapeutics Announces Two Key Milestones Expanding Reimbursement and Access for KIMYRSA™ (oritavancin)
Melinta Therapeutics Announces Two Key Milestones Expanding Reimbursement and Access for KIMYRSA™ (oritavancin)
KIMYRSA™ Receives Product-Specific J-Code and Transitional Pass-Through Status from CMS